Insider · CIK 0001198330

NOHRA GUY P

Reports to the SEC for 27 companies · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001198330

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	TELATELA Bio, Inc.A Award	Director	AAward	+11.9K sh	—	—	11,925
2026-06-09	TELATELA Bio, Inc.A Award	Director	AAward	+11.7K sh	—	—	23,600
2026-06-09	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,550
2026-06-09	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.3K sh	—	—	17,335
2026-06-03	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+25.1K sh	—	—	25,146
2026-06-02	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+32.3K sh	—	—	148,892
2026-06-02	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−32.3K sh	—	—	0
2025-12-04	BVSBioventus Inc.S Sale	Director	SSale	−10K sh	$7.57	−$75.7K	116,610
2025-06-03	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+32.3K sh	—	—	32,282
2025-06-02	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.5K sh	—	—	126,610
2025-06-02	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.5K sh	—	—	0
2024-06-11	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+26.5K sh	—	—	26,493
2024-06-07	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30.4K sh	—	—	100,117
2024-06-07	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−30.4K sh	—	—	0
2023-08-16	BVSBioventus Inc.J Other	Director	JOther	−2.6M sh	—	—	0
2023-08-16	BVSBioventus Inc.J Other	Director	JOther	+41.4K sh	—	—	69,717
2023-06-07	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+30.4K sh	—	—	30,400
2023-06-06	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.6K sh	—	—	28,348
2023-06-06	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−16.6K sh	—	—	0
2022-06-17	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+16.6K sh	—	—	16,648
2022-04-01	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,700 sh	—	—	11,700
2022-04-01	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	0
2022-02-11	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	—	—	9,000
2022-02-11	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	0
2021-04-01	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,700 sh	—	—	2,700
2021-03-04	Allakos Inc.S Sale	10% Owner	SSale	−2,300 sh	$108.89	−$250K	23,468
2021-03-04	Allakos Inc.S Sale	10% Owner	SSale	−4,011 sh	$109.89	−$441K	19,457
2021-03-04	Allakos Inc.S Sale	10% Owner	SSale	−3,142 sh	$110.84	−$348K	16,315
2021-03-04	Allakos Inc.S Sale	10% Owner	SSale	−5,886 sh	$111.80	−$658K	10,429
2021-03-04	Allakos Inc.S Sale	10% Owner	SSale	−9,303 sh	$113.01	−$1.05M	1,126
2021-03-04	Allakos Inc.S Sale	10% Owner	SSale	−1,126 sh	$113.57	−$128K	0
2021-02-11	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+9,000 sh	—	—	9,000
2020-06-17	Allakos Inc.S Sale	10% Owner	SSale	−5,672 sh	$75.23	−$427K	2,020
2020-06-17	Allakos Inc.S Sale	10% Owner	SSale	−1,414 sh	$76.52	−$108K	606
2020-06-17	Allakos Inc.S Sale	10% Owner	SSale	−606 sh	$77.21	−$46.8K	0
2015-12-17	ZS Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	$90.00	−$90K	0
2015-12-17	ZS Pharma, Inc.Stock Options (NQ) - 8/22/14D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2015-12-17	ZS Pharma, Inc.Stock Options (NQ) - BOD 6/18/15D Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2015-06-18	ZS Pharma, Inc.Stock Options (right to buy)A Award	Director	AAward	+4,000 sh	$55.57	+$222K	4,000
2015-06-18	ZS Pharma, Inc.Restricted Stock UnitA Award	Director	AAward	+1,000 sh	—	—	1,000
2015-04-14	KalVista Pharmaceuticals, Inc.C Conversion	Director	CConversion	+728K sh	—	—	727,590
2015-04-14	KalVista Pharmaceuticals, Inc.C Conversion	Director	CConversion	+1.98M sh	—	—	2,708,714
2015-04-14	KalVista Pharmaceuticals, Inc.C Conversion	Director	CConversion	+424K sh	—	—	3,133,060
2015-04-14	KalVista Pharmaceuticals, Inc.C Conversion	Director	CConversion	+333K sh	—	—	3,466,050
2015-04-14	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+878K sh	$5.00	+$4.39M	4,343,550
2015-04-14	KalVista Pharmaceuticals, Inc.Series A Convertible Preferred StockC Conversion	Director	CConversion	−728K sh	—	—	0
2015-04-14	KalVista Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director	CConversion	−1.98M sh	—	—	0
2015-04-14	KalVista Pharmaceuticals, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	−424K sh	—	—	0
2015-04-14	KalVista Pharmaceuticals, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	−333K sh	—	—	0
2014-08-22	ZS Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000

Recent filings

Accepted (ET)
Jun 114
NOHRA GUY P0001198330-26-000007
SEC(opens sec.gov)
Jun 44
NOHRA GUY P0001198330-26-000002
SEC(opens sec.gov)
Dec 84
NOHRA GUY P0001198330-25-000003
SEC(opens sec.gov)
Jun 44
NOHRA GUY P0001578563-25-000308
SEC(opens sec.gov)
Jun 134
NOHRA GUY P0001578563-24-000289
SEC(opens sec.gov)
Jun 114
NOHRA GUY P0001578563-24-000270
SEC(opens sec.gov)
Aug 234/A
NOHRA GUY P0001578563-23-000075
SEC(opens sec.gov)
Aug 184
NOHRA GUY P0001209191-23-046658
SEC(opens sec.gov)
Jun 84
NOHRA GUY P0001578563-23-000042
SEC(opens sec.gov)
Jun 224
NOHRA GUY P0000899243-22-023649
SEC(opens sec.gov)

Address

C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24

MALVERN, PA, 19355